Pioneering Neurotechnology for Humanity

MyraNeuro leads global neuroscience innovation through cutting-edge AI research and strategic partnerships with NASA, Neuralink, and top academic institutions.

About Our Mission

Our Vision

To revolutionize neurological care through AI-powered diagnostics and personalized treatment solutions on a global scale, making advanced brain health accessible to all.

Our Mission

Develop advanced machine learning algorithms for early detection and customized treatment of neurological disorders, bridging the gap between neuroscience and technology.

Our Values

Scientific integrity, patient privacy, technological innovation, and global collaboration drive everything we do in pursuit of better brain health worldwide.

Global Research Initiatives

Advancing Neurodegenerative Research

Our international team collaborates with leading institutions to develop AI models for early detection of Alzheimer's, Parkinson's, and other neurodegenerative diseases. Our patented algorithms analyze multimodal data including MRI, genetic markers, and cognitive assessments to predict disease progression with 89% accuracy.

Current projects include:

  • Longitudinal prediction models for dementia progression
  • Digital biomarkers for Parkinson's disease monitoring
  • AI-powered drug discovery for neurodegeneration
  • NASA-funded research on microgravity effects on brain health

Stroke Recovery Innovations

Our stroke research focuses on AI-assisted rehabilitation and recovery prediction. Using advanced neural networks, we analyze post-stroke brain imaging to customize rehabilitation protocols and predict recovery trajectories with 83% precision across diverse populations.

Key initiatives:

  • Automated lesion segmentation and analysis
  • Personalized neurorehabilitation planning
  • Global stroke outcome prediction models
  • Neuralink integration for motor recovery

Brain-Computer Interface Breakthroughs

We're developing next-generation BCI systems using deep learning analysis of neural signals. Our collaboration with Neuralink has demonstrated 78% accuracy in thought-to-action translation, significantly improving quality of life for patients with mobility impairments.

Research highlights:

  • Non-invasive EEG-based control systems
  • AI-powered neural signal decoding
  • Multicenter BCI data consortium
  • NASA applications for astronaut cognitive monitoring

Our Technology Platform

NeuroAI Analytics

Our proprietary deep learning framework processes multimodal neurological data with industry-leading accuracy across diverse populations.

Neural Mapping

Advanced image processing and machine learning for automated detection of neurological abnormalities in MRI and CT scans.

MyraBot Interface

AI-powered virtual neurologist assistant providing preliminary assessments and follow-up care recommendations in multiple languages.

NASA Space Neuroscience Program

Our collaboration with NASA focuses on understanding how spaceflight affects brain health. We're developing AI models to monitor astronaut cognitive function during long-duration missions and create countermeasures for space-related neurological changes.

NASA Research

Leadership Team

Chief Science Officer

PhD in Computational Neuroscience

15+ years in neurological research

Former NASA consultant

Chief Technology Officer

Expert in Medical AI Systems

10+ patents in neurotechnology

Neuralink collaborator

Chief Medical Officer

Board Certified Neurologist

Clinical research specialist

Space medicine expert

Global Partners

We collaborate with leading organizations worldwide to advance neurological research and develop innovative solutions.

Contact Our Team

Global Headquarters

Neurotech Research Park, Building A

International Neuroscience Campus

+1 (555) 123-4567

info@myraneuro.com

Research Inquiries

Monday - Friday: 9:00 - 18:00 GMT

research@myraneuro.com